International CRO LGC, a U.K.-based provider of laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces, and CRO TranScrip Partners are collaborating to combine and enhance their offerings to clients, particularly in the areas of anti-infectives and respiratory disease.

TranScrip Partners supplies a range of services including drug development and operations, regulatory affairs, microbiology, medical writing, translational medicine, drug safety and pharmacovigilance. LGC is a provider of high-integrity analytical laboratory services to support drug discovery, development and manufacture. With last year’s acquisition of Quotient Bio Analytical Sciences, LGC also has a bioanalytical facility with experience spanning small molecules, biopharmaceuticals, biomarkers, microbiology and molecular services.